Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00636337 · ClinicalTrials.gov registry record · NA

Inattention in Childhood Cancer Survivors

A NA study of Childhood Cancer, sponsored by Duke University.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT00636337: Completed NA study of Childhood Cancer, sponsored by Duke University.

NCT00636337 is a NA study of Childhood Cancer that has completed, run by Duke University. The registered enrollment target is 23 participants, below the 1,471-participant average among 23 other Childhood Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00636337, a NA study of Childhood Cancer, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

Specific Aim 1: To assess the feasibility and acceptability of a home-based, computerized cognitive training program with survivors of central nervous system-impacting pediatric cancer (e.g. acute lymphoblastic leukemia, brain tumors). Specific Aim 2: To estimate the effect size of this cognitive training program on measures of attention and working memory in survivors of childhood cancer in order to determine whether a larger-scale clinical trial is warranted.

Conditions Studied

Interventions

  • BEHAVIORAL Placebo
  • BEHAVIORAL Attention Training

Study Locations (1)

North Carolina

  • Duke University Medical Center Preston Robert Tisch Brain Tumor Center - Durham

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2007-12
Est. Completion 2012-11
Phase NA
Duke University

1,725 total trials

What the finished NCT00636337 record still lists

NCT00636337 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,471-participant average among 23 other Childhood Cancer trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Childhood Cancer appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00636337 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT00636337 about?

NCT00636337 is a clinical study titled "Inattention in Childhood Cancer Survivors". Specific Aim 1: To assess the feasibility and acceptability of a home-based, computerized cognitive training program with survivors of central nervous system-impacting pediatric cancer (e.g. acute lymphoblastic leukemia, brain tumors). Specific Aim 2: To estimate the effect size of this cognitive t...

What is the current status of trial NCT00636337?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2007-12. Estimated completion is 2012-11.

What conditions does trial NCT00636337 study?

This clinical trial studies the following conditions: Childhood Cancer.

What interventions are being tested in trial NCT00636337?

The interventions under investigation include: Placebo (BEHAVIORAL), Attention Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT00636337?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00636337 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Childhood Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00636337's enrollment target sits among peer trials

23 18th of 23 higher than 6 of 23 other Childhood Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Childhood Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00636337, the US trial registry maintained by the National Library of Medicine. NCT00636337 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.